Clinical Trial Update: OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxycodone-PR versus placebo in opioid-naive adults with severe pain due to bladder pain syndrome/interstitial cystitis; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis
• Pain
• Painful Bladder Syndrome

Drugs mentioned

• OXN PR (Oxycodone/naloxone prolonged-release)

Snippet

Sponsor: Mundipharma Research GmbH & Co KG | Conditions: Interstitial Cystitis, Painful Bladder Syndrome | Phase 2 | Status: COMPLETED